loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Sarizotan, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Sarizotan

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Biopharma Group offers CDMO services with expertise in contract R&D for dried products & liquid formulations.

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    2D Structure
    1. Also known as: Sarizotan [inn], 351862-32-3, 467lu0ucuw, Emd-77697, 1-[(2r)-3,4-dihydro-2h-chromen-2-yl]-n-[[5-(4-fluorophenyl)pyridin-3-yl]methyl]methanamine, 1-(5-(4-fluorophenyl)pyridin-3-yl)-n-((2r)-3,4,4a,8a-tetrahydro-2h-chromen-2-ylmethyl)methanamine
    Molecular Formula
    C22H21FN2O
    Molecular Weight
    348.4  g/mol
    InChI Key
    HKFMQJUJWSFOLY-OAQYLSRUSA-N
    FDA UNII
    467LU0UCUW
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    1-[(2R)-3,4-dihydro-2H-chromen-2-yl]-N-[[5-(4-fluorophenyl)pyridin-3-yl]methyl]methanamine
    2.1.2 InChI
    InChI=1S/C22H21FN2O/c23-20-8-5-17(6-9-20)19-11-16(12-24-14-19)13-25-15-21-10-7-18-3-1-2-4-22(18)26-21/h1-6,8-9,11-12,14,21,25H,7,10,13,15H2/t21-/m1/s1
    2.1.3 InChI Key
    HKFMQJUJWSFOLY-OAQYLSRUSA-N
    2.1.4 Canonical SMILES
    C1CC2=CC=CC=C2OC1CNCC3=CC(=CN=C3)C4=CC=C(C=C4)F
    2.1.5 Isomeric SMILES
    C1CC2=CC=CC=C2O[C@H]1CNCC3=CC(=CN=C3)C4=CC=C(C=C4)F
    2.2 Other Identifiers
    2.2.1 UNII
    467LU0UCUW
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Emd128130

    2. Sarizotan Hydrochloride

    2.3.2 Depositor-Supplied Synonyms

    1. Sarizotan [inn]

    2. 351862-32-3

    3. 467lu0ucuw

    4. Emd-77697

    5. 1-[(2r)-3,4-dihydro-2h-chromen-2-yl]-n-[[5-(4-fluorophenyl)pyridin-3-yl]methyl]methanamine

    6. 1-(5-(4-fluorophenyl)pyridin-3-yl)-n-((2r)-3,4,4a,8a-tetrahydro-2h-chromen-2-ylmethyl)methanamine

    7. 3-pyridinemethanamine, 5-(4-fluorophenyl)-n-(((2r)-3,4,4a,8a-tetrahydro-2h-1-benzopyran-2-yl)methyl)-

    8. Unii-467lu0ucuw

    9. (-)-(r)-n-(3,4-dihydro-2h-1-benzofuran-2-ylmethyl)-n-[5-(4-fluorophenyl)-3-pyridylmethyl]amine

    10. 195068-07-6

    11. Sarizotan [mi]

    12. Sarizotan [who-dd]

    13. Schembl120080

    14. Chembl220808

    15. Zinc21067

    16. Bdbm50027256

    17. Db06454

    18. Hy-100820

    19. Cs-0020461

    20. A1-26903

    21. Q7424144

    22. (r)-(+)-2-[5-(4-fluorphenyl)-3-pyridylmethylaminomethyl]-chromane

    23. (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman

    24. (r)-1-(chroman-2-yl)-n-((5-(4-fluorophenyl)pyridin-3-yl)methyl)methanamine

    25. 3-pyridinemethanamine, N-(((2r)-3,4-dihydro-2h-1-benzopyran-2-yl)methyl)-5-(4-fluorophenyl)-

    2.4 Create Date
    2006-07-28
    3 Chemical and Physical Properties
    Molecular Weight 348.4 g/mol
    Molecular Formula C22H21FN2O
    XLogP34.1
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count5
    Exact Mass348.16379146 g/mol
    Monoisotopic Mass348.16379146 g/mol
    Topological Polar Surface Area34.2 Ų
    Heavy Atom Count26
    Formal Charge0
    Complexity426
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Investigated for use/treatment in schizophrenia and schizoaffective disorders and parkinson's disease.

    Post Enquiry
    POST ENQUIRY